Related Experiment Video
Updated: Mar 14, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Long-term home monitoring of intraocular pressure in pediatric glaucoma
Derek P Bitner1, Sharon F Freedman1
1Duke University Department of Ophthalmology, Durham, North Carolina.
Insights
Long-term home monitoring of intraocular pressure (IOP) is feasible in pediatric glaucoma, revealing significant diurnal fluctuations. Outflow-enhancing interventions effectively reduced both mean IOP and its daily variability in children.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Glaucoma Research
Background:
- Diurnal fluctuation of intraocular pressure (IOP) is a known factor in adult glaucoma progression.
- Previous studies on pediatric glaucoma have limited data on IOP fluctuations, mostly from short-term monitoring.
- Understanding long-term IOP patterns is crucial for managing pediatric glaucoma.
Purpose of the Study:
- To evaluate long-term intraocular pressure (IOP) fluctuation patterns in children with glaucoma.
- To assess the impact of outflow-enhancing interventions on IOP variability in pediatric glaucoma.
- To establish the feasibility of home-based IOP monitoring in this population.
Main Methods:
- Prospective study utilizing parent-measured, home-based rebound tonometry in pediatric glaucoma patients.
- Monitoring IOP for over a month with at least three daily measurements.
- Collecting demographic and glaucoma-specific data, and evaluating IOP trends, including spikes and pre/post-intervention changes.
Main Results:
- Feasible long-term home monitoring of IOP in 14 eyes of 7 children over a mean of 164 days.
- Significant reduction in mean IOP (26.6 to 15.5 mm Hg) and daily fluctuation (8.4 to 4.6 mm Hg) after outflow improvement.
- A 14-day monitoring period offered a >90% chance of detecting an intraocular pressure spike.
Conclusions:
- Long-term home IOP monitoring is a viable method for pediatric glaucoma patients.
- Pediatric glaucoma patients exhibit substantial IOP fluctuations.
- Outflow-enhancing interventions successfully decrease both mean IOP and its daily fluctuations in children.
Purpose:
Diurnal fluctuation of intraocular pressure (IOP), implicated in progression of adult glaucoma, has been reported in children only in the context of office and short-term home monitoring. The purpose of this study was to evaluate long-term patterns of IOP fluctuation and changes resulting from outflow-enhancing intervention in pediatric glaucoma.
Methods:
Parent-measured home-based rebound tonometry (Icare, Finland Oy) in pediatric glaucoma patients was studied prospectively. IOP was monitored for more than 1 month, with requested measurements at least 3 times daily. Demographic and glaucoma-related information were collected for each participant. IOP was recorded at home on electronic data sheets. It was then evaluated for trends including mean overall IOP, IOP pre- and post-planned IOP-lowering interventions, and IOP spikes over determined time intervals.
Results:
IOP was measured in 14 eyes of 7 children (mean age, 9.3 ± 2.4 years) over a mean of 164.3 days (range, 75-341), with a mean of 2.46 readings daily. Six eyes of 5 children underwent attempted outflow improvement, with improved mean IOP before versus after intervention (26.6 vs 15.5 mm Hg, P < 0.0001) and decreased mean daily IOP fluctuation (8.4 vs 4.6 mm Hg, P < 0.001) for each. An IOP reading 20% greater than mean for an individual eye over the entire period (a pressure "spike") occurred in 19.3 ± 6.7% over 1 day, 62.9 ± 18.0% over 3 days, 80.8 ± 12.2% over 7 days, and 92.9 ± 9.4% over 14 days.
Conclusions:
Long-term home monitoring in pediatric glaucoma proved feasible in this study population and often demonstrated large IOP fluctuations. A 14-day period of home monitoring provided >90% chance of identifying an IOP spike. Successful outflow improvement lowered both mean IOP and mean daily IOP fluctuations.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

